Abingdon, United Kingdom

Manus Dennison

This inventor holds 1 USPTO granted patent. Top assignee: Medisense, Inc.. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 500(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manus Dennison: Innovator in Amperometric Sensing Technology

Introduction

Manus Dennison is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of sensor technology, particularly through his innovative work on amperometric sensors. His expertise and dedication to advancing technology have led to the development of a unique patent that enhances the capabilities of these sensors.

Latest Patents

Manus Dennison holds a patent for an "Enhanced Amperometric Sensor." This invention comprises a working electrode, a reference electrode, an enzyme whose catalytic activity on a substrate results in electroactivity, and an enhancer compound that improves the detected electroactivity. This advancement has the potential to significantly improve the performance of amperometric sensors in various applications.

Career Highlights

Throughout his career, Manus has been associated with Medisense, Inc., where he has contributed to the development of innovative sensing technologies. His work has not only advanced the field but has also positioned Medisense, Inc. as a leader in sensor technology.

Collaborations

Manus has collaborated with talented individuals such as Jerome F McAleer and Lesley Scott. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Manus Dennison is a distinguished inventor whose work in amperometric sensing technology has made a significant impact. His patent for the enhanced amperometric sensor showcases his innovative spirit and commitment to advancing technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…